EUVIMEDEUVIMED entdecken
Validierungsstudie

pREdicting Long‐Term Major advErse carDiac and Cerebrovascular Events After Percutaneous coronarY Intervention: The REMEDY Score

Jiaxi Cheng, Chenxi Song, Hao-Yu Wang, Zhangyu Lin, Zheng Qiao, Xiaohui Bian, Lei Feng, Chenggang Zhu, Min Yang, Guofeng Gao iD, Dong Yin, Kefei Dou iD

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.70244 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Jiaxi Cheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Chinese Academy of Medical Sciences and Peking Union Medical College, Cardiometabolic Medicine Center, Fuwai Hospital, National Center for Cardiovasc…. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Decision Support Techniques, Coronary Artery Disease, Stroke. Die Arbeit nennt 47 Literaturangaben. Gefördert von: This study was funded by the CAMS Innovation Fund for Medical Sciences (CIFMS, grant number 2021-I2M-1-008), Noncommunicable Chronic Diseases-National Science….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A clinically applicable tool incorporating comprehensive risk factors to evaluate long‐term hard endpoints post‐percutaneous coronary intervention (PCI) is currently lacking.

Aims

This study aims to develop a risk score from a large contemporary cohort to assess and stratify long‐term risk of major adverse cardiac and cerebrovascular events (MACCEs) post‐PCI, enabling proactive management and monitoring in high‐risk patients.

Methods

The study prospectively enrolled 28,683 consecutive patients undergoing PCI from 2017 to 2018, assigning the first 70% for score derivation and the remaining 30% for validation. The primary endpoint was 3‐year MACCEs, including cardiovascular death, myocardial infarction, and stroke. A LASSO‐Cox model identified 10 independent predictors, from which a weighted integer scoring system was developed.

Results

Within 3 years post‐PCI, 1013 MACCEs (3.5%) were observed. A risk score incorporating three demographic factors (age, severe coronary artery disease history, hypertension duration), two clinical characteristics (left ventricular ejection fraction, clinical presentation), two angiographic features (affected vessels, calcification severity), and three laboratory results (glycated hemoglobin, N‐terminal pro‐B‐type natriuretic peptide, estimated glomerular filtration rate) demonstrated strong predictive performance (c‐index 0.764, AUC 0.831, goodness‐of‐fit p = 0.34). Patients were stratified into low (score 0–4, risk ≤ 2%), moderate (score 5–8, 2% < risk ≤ 5%), and high risk (score ≥ 9, risk > 5%), with corresponding 3‐year MACCE incidences of 1.6%, 4.0%, and 10.1%.

Conclusions

A contemporary simple risk score integrating 10 readily available variables accurately predicts long‐term hard outcomes in PCI patients, facilitating personalized risk assessment and informed treatment decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionDecision Support TechniquesCoronary Artery DiseaseStrokeCerebrovascular DisordersHumansRisk AssessmentMaleFemaleTime FactorsAgedMiddle AgedPredictive Value of TestsTreatment OutcomeProspective StudiesRisk FactorsReproducibility of Results

Stichwörter der Autor:innen

long‐term outcomesmajor adverse cardiac and cerebrovascular eventspercutaneous coronary interventionprognostic risk scorerisk stratification

Autor:innen und Institutionen

  • Chinese Academy of Medical Sciences and Peking Union Medical College, Cardiometabolic Medicine Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Beijing, China.
  • Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • State Key Laboratory of Cardiovascular Disease, Beijing, China.
  • National Clinical Research Center for Cardiovascular Diseases, Beijing, China.

ORCID-Profile: Guofeng Gao, Kefei Dou

Förderung

  • This study was funded by the CAMS Innovation Fund for Medical Sciences (CIFMS, grant number 2021-I2M-1-008), Noncommunicable Chronic Diseases-National Science…

Zitieren

APA

Cheng, J., Song, C., Wang, H. Y., Lin, Z., Qiao, Z., Bian, X., Feng, L., Zhu, C., Yang, M., Gao, G., Yin, D., & Dou, K. (2025). pREdicting Long‐Term Major advErse carDiac and Cerebrovascular Events After Percutaneous coronarY Intervention: The REMEDY Score. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70244

Vancouver

Cheng J, Song C, Wang HY, Lin Z, Qiao Z, Bian X, et al. pREdicting Long‐Term Major advErse carDiac and Cerebrovascular Events After Percutaneous coronarY Intervention: The REMEDY Score. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70244

BibTeX
@article{Cheng2025,
  author = {Cheng, Jiaxi and Song, Chenxi and Wang, Hao-Yu and Lin, Zhangyu and Qiao, Zheng and Bian, Xiaohui and Feng, Lei and Zhu, Chenggang and Yang, Min and Gao, Guofeng and Yin, Dong and Dou, Kefei},
  title = {pREdicting Long‐Term Major advErse carDiac and Cerebrovascular Events After Percutaneous coronarY Intervention: The REMEDY Score},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.70244}
}
Kostenlos starten →